Continuing Medical Education (CME): Flawed JAMA Report Blurs Line Between “Medical Communication Companies” and Accredited “Medical Education Companies”

Today, the Journal of the American Medical Association (JAMA) published a brief report (Medical Communication Companies and Industry Grants) as well as an editorial in order to explore "the financial relationships between MCCs and drug device companies." The authors use a mixture of outdated figures, hyperbole, and blatant untruths to piece together their articles, which, according to CME Coalition Senior Advisor, Andrew Rosenberg, contain "so many inaccuracies and examples of unfounded innuendo" that "it is a challenge to enumerate them all." JAMA has decided not to make the report available to the public, but we have compiled the report's content. JAMA erroneously interchanges Medical Communication Companies with Medical Education Companies: Grant Donations 2010     Roche/Genentech  106,916,052  Merck  99,481,044  Pfizer  89,520,722  Abbott  69,518,593  Eli Lilly  54,767,686 Bristol-Myers Squibb  43,570,166  Amgen  43,383,578  AstraZeneca  35,628,747  Sanofi-Aventis  34,404,149  GlaxoSmithKline  29,658,381  Medtronic  26,125,342  Astellas  11,905,202  Forest Laboratories  9,400,372  Shire  3,987,736  Total*  658,267,770  Note the JAMA Article has the total of 657,643,322 – excel addition did not mat...
Source: Policy and Medicine - Category: Health Medicine and Bioethics Commentators Authors: Source Type: blogs